On September 19th, VTR stated at the performance briefing that due to market reasons, the company has currently halted the production of Vitamin B12. In terms of plant extracts for animals, the company has continued to conduct pharmacological research and toxicological tests related to the whole plant of Bo Luo Hui in the first half of the year. They completed trials on Bo Luo Hui powder for laying hens, "Mei Zhuo Yi" for broilers, Bo Pu total alkaloid powder for breeding chickens, and mulberry bark water extract for laying hens, obtaining new product certificates for red clover extract and stone mint extract as feed and feed additives. In terms of plant extracts for humans, the company developed products such as fermented sour cherry frozen fruit, bamboo leaf extract, berberine bark extract, and echinacea microcrystalline cellulose composite powder in the first half of the year. At the same time, they optimized the extraction processes for plants such as sorghum, reishi mushroom, hibiscus, and cocoa, continuously expanding overseas markets and increasing sales in Europe and Southeast Asia. The preparations for the German subsidiary have been completed, aiming for a sales breakthrough this year